Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)
This study is currently recruiting participants.
Verified May 2013 by University of Vermont
Sponsor:
James BOYD MD
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by (Responsible Party):
James BOYD MD, University of Vermont
ClinicalTrials.gov Identifier:
NCT01560754
First received: March 9, 2012
Last updated: May 8, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |